This inventor holds 2 USPTO granted patents. Top assignee: Ciba-Geigy Corporation. Active years: 1976-1977.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1976-1977
Title: Friedrich Werner Kahnt: Innovator in Thyrocalcitonin and Hypocalcaemic Peptides
Introduction
Friedrich Werner Kahnt is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of biochemistry, particularly in the development of peptides that have important medical applications. With a total of 2 patents, Kahnt's work has had a lasting impact on the scientific community.
Latest Patents
Kahnt's latest patents include a process for the manufacture of thyrocalcitonin, which involves extracting pure thyrocalcitonin from thyroid gland tissue using a solvent system containing water and a lower alkanol at a pH of about 1-6. Additionally, he has developed synthetic hypocalcaemic peptides, specifically a dotriacontapeptide of a defined formula, which has potential therapeutic uses.
Career Highlights
Throughout his career, Kahnt has been associated with Ciba-Geigy Corporation, a prominent company in the pharmaceutical and chemical sectors. His innovative approaches to peptide synthesis have contributed to advancements in medical treatments and research.
Collaborations
Kahnt has worked alongside esteemed colleagues such as Robert Neher and Max Brugger, further enhancing the collaborative spirit of scientific research.
Conclusion
Friedrich Werner Kahnt's contributions to the field of biochemistry, particularly through his patents on thyrocalcitonin and hypocalcaemic peptides, underscore his role as a significant inventor. His work continues to influence the development of medical therapies and research methodologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile